Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01407744 · ClinicalTrials.gov registry record

Study of Tumor Samples From Patients With Ependymoma Treated on the Children's Oncology Group ACNS0121 Trial

A clinical trial of Childhood Infratentorial Ependymoma and Childhood Supratentorial Ependymoma, sponsored by Children's Oncology Group.

Completed
Registry status
80
Enrollment target
1
Study location

NCT01407744 is a study of Childhood Infratentorial Ependymoma and Childhood Supratentorial Ependymoma that has completed, run by Children's Oncology Group. The registered enrollment target is 80 participants. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01407744, a study of Childhood Infratentorial Ependymoma and Childhood Supratentorial Ependymoma, has completed, sponsored by Children's Oncology Group.

COMPLETED
Registry status
80 participants
Enrollment target
1
Study location

Study Summary

This research trial studies tumor samples from patients with ependymoma treated on the Children Oncology Group ACNS0121 trial. Studying samples of tumor tissue from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer. It may also help doctors find better ways to treat cancer.

Interventions

  • OTHER laboratory biomarker analysis

Study Locations (1)

California

  • Children's Oncology Group - Monrovia

Trial Details

FieldValue
Enrollment Target 80 participants
Start Date 2012-03
Est. Completion 2013-04

Sponsor

Children's Oncology Group

342 total trials

What the Registry Record Tells You About NCT01407744

The ClinicalTrials.gov registry entry for NCT01407744 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Children's Oncology Group, which has 342 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Childhood Infratentorial Ependymoma appearing as the primary indexed condition, and to 1 intervention - of which laboratory biomarker analysis is the first listed.

NCT01407744 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT01407744 about?

NCT01407744 is a clinical study titled "Study of Tumor Samples From Patients With Ependymoma Treated on the Children's Oncology Group ACNS0121 Trial". This research trial studies tumor samples from patients with ependymoma treated on the Children Oncology Group ACNS0121 trial. Studying samples of tumor tissue from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to c...

What is the current status of trial NCT01407744?

This trial is currently completed. The enrollment target is 80 participants. The study started on 2012-03. Estimated completion is 2013-04.

What conditions does trial NCT01407744 study?

This clinical trial studies the following conditions: Childhood Infratentorial Ependymoma, Childhood Supratentorial Ependymoma, Newly Diagnosed Childhood Ependymoma.

What interventions are being tested in trial NCT01407744?

The interventions under investigation include: laboratory biomarker analysis (OTHER).

Who is sponsoring clinical trial NCT01407744?

This trial is sponsored by Children's Oncology Group, which has 342 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01407744 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Childhood Infratentorial Ependymoma

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.